Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy-

Request For Quotation
Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Mashilabs (Shanghai) Co.,Ltd.  
Tel: 19916721580
Email: mafarm@126.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696，15000506266 15000506266
Email:
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com

Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- manufacturers

  • FTO-IN-1
  • FTO-IN-1 pictures
  • $78.00
  • 2026-07-27
  • CAS:2243944-92-3
  • Purity: 99.43%
  • Supply Ability: 10g
Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Basic information
Product Name:Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy-
Synonyms:Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy-;UUN44923;FTO-IN-1;Dac51，UUN-44923;mass,cancer,FTO,associated,enzyme,inhibit,FTOIN1,fat,obesity,Inhibitor,FTO IN 1;2-[[2,6-Dichloro-4-(3,5-dimethyl-4-pyrazolyl)phenyl]amino]-N-hydroxybenzamide;2-((2,6-Dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl)amino)-N-hydroxybenzamide;FTO-IN-1, 10 mM in DMSO
CAS:2243944-92-3
MF:C18H16Cl2N4O2
MW:391.25
EINECS:
Product Categories:
Mol File:2243944-92-3.mol
Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Structure
Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Chemical Properties
density 1.448±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 100 mg/mL (197.91 mM);Water: Insoluble;Ethanol: Insoluble
pka8.72±0.40(Predicted)
Safety Information
MSDS Information
Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Usage And Synthesis
DescriptionUUN44923 is a FTO inhibitor. UUN44923 may be useful for treating diseases assocd. with FTO targets, obesity, metabolic syndrome (MS), type 2 diabetes (T2D), Alzheimer's diseases, breast cancers, small-cell lung cancers, a human bone marrow striated muscle cancer, a pancreatic cancer, malignant glioblastoma and the like. UUN44923 was reported in WO 2018157843. This product has no formal name at the moment.
UsesFTO-IN-1 is a fat mass and obesity-associated enzyme (FTO) inhibitor extracted from patent WO2018157843A1, compound 32, with an IC50 of <1 μM. FTO-IN-1 can be used for the research of cancer[1].
References[1] Yang C, et, al. 2-(substituted benzene matrix) aromatic formate fto inhibitor, preparation method therefor, and applications thereof. WO2018157843A1.
Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Preparation Products And Raw materials
Tag:Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy-(2243944-92-3) Related Product Information
FTO-IN-1 TFA Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- FTO-IN-14 3-Methylthymidine 4-Quinolinol, 8-fluoro-2-[[3-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]methyl]- 1H-Pyrazole-4-carboxamide, N-[(4-ethylphenyl)methyl]-3,5-dimethyl-1-(phenylmethyl)-N-(3-pyridinylmethyl)-